Breztri Aerosphere (PT010) approved in Japan for patients with chronic obstructive pulmonary disease
AstraZeneca today announced that Breztri Aerosphere (budesonide/glycopyrronium/ formoterol fumarate), formerly PT010, has been approved in Japan as a triple-combination therapy to relieve s...